Newsletter - April 16, 2020
Pandemic is Boom Time of Digital Health Companies
The “Stay at Home” orders have created a once-in-a-lifetime opportunity for information tech companies to build and test digital health tools that would live way beyond the pandemic. All those concerns for privacy and of digital health companies exploiting our personal health information for their financial gains have gone out...Read More
How Easy is it to Get an IND from FDA for a COVID-19 Drugs?
Typically, an IND application requires months and years of research and development, and a reasonable rationale for the potential treatment. Since the announcement of the pandemic about 2-3 months ago, there have been hundreds of clinical trials initiated for products intended to treat or prevent the disease. This may seem like...Read More
Pandemic is Boom Time of Digital Health Companies
The “Stay at Home” orders have created a once-in-a-lifetime opportunity for information tech companies to build and test digital health tools that would live way beyond the pandemic. All those concerns for privacy and of digital health companies exploiting our personal health information for their financial gains have gone out...Read More
How Easy is it to Get an IND from FDA for a COVID-19 Drugs?
Typically, an IND application requires months and years of research and development, and a reasonable rationale for the potential treatment. Since the announcement of the pandemic about 2-3 months ago, there have been hundreds of clinical trials initiated for products intended to treat or prevent the disease. This may seem like...Read More
